Viewing Study NCT05599295


Ignite Creation Date: 2025-12-24 @ 1:38 PM
Ignite Modification Date: 2025-12-30 @ 7:48 AM
Study NCT ID: NCT05599295
Status: COMPLETED
Last Update Posted: 2025-11-25
First Post: 2022-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections
Sponsor: Melinta Therapeutics, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module